APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cilostazol

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cilostazol Industry Growth and Trends Forecast to 2032

Report ID 173978150126 December 2025112 pages

Choose your research edition.

Industry ResearchCilostazol Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Cilostazol Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cilostazol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cilostazol Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Cilostazol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Cilostazol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cilostazol include Chongqing Pharscin pharmaceutical, Zhejiang Weikang Pharmaceutical, Abbott, Takeda, Teva, Novartis, Mylan, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cilostazol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cilostazol market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cilostazol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cilostazol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cilostazol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cilostazol Market by Company

Chongqing Pharscin pharmaceutical

Zhejiang Weikang Pharmaceutical

Abbott

Takeda

Teva

Novartis

Mylan

Pfizer

GSK

Chengdu Leer Pharmaceutical

Yantai Yisheng Pharmaceutical

Squibb

Sandoz

Otsuka Pharmaceutical

Mayne Pharma

Hikma Pharmaceuticals

Cadila Pharmaceuticals

Bedford Laboratories

Cilostazol Segment by Type

Injection Cilostazol

Oral Cilostazol

Freeze-dried Powder Cilostazol

Cilostazol Segment by Application

Hospital

Clinic

Others

Cilostazol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cilostazol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cilostazol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cilostazol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cilostazol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cilostazol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Cilostazol Table 2. Major Company of Oral Cilostazol Table 3. Major Company of Freeze-dried Powder Cilostazol Table 4. Global Cilostazol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cilostazol Sales by Type (2021-2026) & (K Units) Table 6. Global Cilostazol Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cilostazol Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cilostazol Sales Market Share in Value by Type (2021-2026) Table 9. Global Cilostazol Price by Type (2021-2026) & (US$/Unit) Table 10. Global Cilostazol Sales by Type (2027-2032) & (K Units) Table 11. Global Cilostazol Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cilostazol Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cilostazol Sales Market Share in Value by Type (2027-2032) Table 14. Global Cilostazol Price by Type (2027-2032) & (US$/Unit) Table 15. North America Cilostazol Sales by Type (2021-2026) & (K Units) Table 16. North America Cilostazol Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cilostazol Sales by Type (2021-2026) & (K Units) Table 18. Europe Cilostazol Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cilostazol Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Cilostazol Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cilostazol Sales by Type (2021-2026) & (K Units) Table 22. Latin America Cilostazol Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cilostazol Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Cilostazol Sales by Type (2021-2026) & (US$ Million) Table 25. Cilostazol Industry Trends Table 26. Cilostazol Industry Drivers Table 27. Cilostazol Industry Opportunities and Challenges Table 28. Cilostazol Industry Restraints Table 29. Global Cilostazol Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cilostazol Revenue Market Share by Company (2021-2026) Table 31. Global Cilostazol Sales by Company (2021-2026) & (K Units) Table 32. Global Cilostazol Sales Share by Company (2021-2026) Table 33. Global Cilostazol Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Cilostazol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cilostazol Major Company Production Sites and Headquarters Table 36. Global Cilostazol Company, Product Type & Application Table 37. Global Cilostazol Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cilostazol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cilostazol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cilostazol Sales by Region (2021-2026) & (K Units) Table 42. Global Cilostazol Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cilostazol Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cilostazol Sales Market Share in Value by Region (2021-2026) Table 45. Global Cilostazol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Cilostazol Sales by Region (2027-2032) & (K Units) Table 47. Global Cilostazol Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cilostazol Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cilostazol Sales Market Share in Value by Region (2027-2032) Table 50. Global Cilostazol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Cilostazol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cilostazol Sales by Application (2021-2026) & (K Units) Table 53. Global Cilostazol Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cilostazol Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cilostazol Sales Market Share in Value by Application (2021-2026) Table 56. Global Cilostazol Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cilostazol Sales by Application (2027-2032) & (K Units) Table 58. Global Cilostazol Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cilostazol Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cilostazol Sales Market Share in Value by Application (2027-2032) Table 61. Global Cilostazol Price by Application (2027-2032) & (US$/Unit) Table 62. North America Cilostazol Sales by Application (2021-2026) & (K Units) Table 63. North America Cilostazol Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cilostazol Sales by Application (2021-2026) & (K Units) Table 65. Europe Cilostazol Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cilostazol Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Cilostazol Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cilostazol Sales by Application (2021-2026) & (K Units) Table 69. Latin America Cilostazol Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cilostazol Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Cilostazol Sales by Application (2021-2026) & (US$ Million) Table 72. Chongqing Pharscin pharmaceutical Company Information Table 73. Chongqing Pharscin pharmaceutical Business Overview Table 74. Chongqing Pharscin pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Chongqing Pharscin pharmaceutical Cilostazol Product Portfolio Table 76. Chongqing Pharscin pharmaceutical Recent Development Table 77. Zhejiang Weikang Pharmaceutical Company Information Table 78. Zhejiang Weikang Pharmaceutical Business Overview Table 79. Zhejiang Weikang Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolio Table 81. Zhejiang Weikang Pharmaceutical Recent Development Table 82. Abbott Company Information Table 83. Abbott Business Overview Table 84. Abbott Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Abbott Cilostazol Product Portfolio Table 86. Abbott Recent Development Table 87. Takeda Company Information Table 88. Takeda Business Overview Table 89. Takeda Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Takeda Cilostazol Product Portfolio Table 91. Takeda Recent Development Table 92. Teva Company Information Table 93. Teva Business Overview Table 94. Teva Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Teva Cilostazol Product Portfolio Table 96. Teva Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novartis Cilostazol Product Portfolio Table 101. Novartis Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mylan Cilostazol Product Portfolio Table 106. Mylan Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Cilostazol Product Portfolio Table 111. Pfizer Recent Development Table 112. GSK Company Information Table 113. GSK Business Overview Table 114. GSK Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GSK Cilostazol Product Portfolio Table 116. GSK Recent Development Table 117. Chengdu Leer Pharmaceutical Company Information Table 118. Chengdu Leer Pharmaceutical Business Overview Table 119. Chengdu Leer Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Chengdu Leer Pharmaceutical Cilostazol Product Portfolio Table 121. Chengdu Leer Pharmaceutical Recent Development Table 122. Yantai Yisheng Pharmaceutical Company Information Table 123. Yantai Yisheng Pharmaceutical Business Overview Table 124. Yantai Yisheng Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Yantai Yisheng Pharmaceutical Cilostazol Product Portfolio Table 126. Yantai Yisheng Pharmaceutical Recent Development Table 127. Squibb Company Information Table 128. Squibb Business Overview Table 129. Squibb Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Squibb Cilostazol Product Portfolio Table 131. Squibb Recent Development Table 132. Sandoz Company Information Table 133. Sandoz Business Overview Table 134. Sandoz Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sandoz Cilostazol Product Portfolio Table 136. Sandoz Recent Development Table 137. Otsuka Pharmaceutical Company Information Table 138. Otsuka Pharmaceutical Business Overview Table 139. Otsuka Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Otsuka Pharmaceutical Cilostazol Product Portfolio Table 141. Otsuka Pharmaceutical Recent Development Table 142. Mayne Pharma Company Information Table 143. Mayne Pharma Business Overview Table 144. Mayne Pharma Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Mayne Pharma Cilostazol Product Portfolio Table 146. Mayne Pharma Recent Development Table 147. Hikma Pharmaceuticals Company Information Table 148. Hikma Pharmaceuticals Business Overview Table 149. Hikma Pharmaceuticals Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Hikma Pharmaceuticals Cilostazol Product Portfolio Table 151. Hikma Pharmaceuticals Recent Development Table 152. Cadila Pharmaceuticals Company Information Table 153. Cadila Pharmaceuticals Business Overview Table 154. Cadila Pharmaceuticals Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Cadila Pharmaceuticals Cilostazol Product Portfolio Table 156. Cadila Pharmaceuticals Recent Development Table 157. Bedford Laboratories Company Information Table 158. Bedford Laboratories Business Overview Table 159. Bedford Laboratories Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Bedford Laboratories Cilostazol Product Portfolio Table 161. Bedford Laboratories Recent Development Table 162. North America Cilostazol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. North America Cilostazol Sales by Country (2021-2026) & (K Units) Table 164. North America Cilostazol Sales Market Share by Country (2021-2026) Table 165. North America Cilostazol Sales Forecast by Country (2027-2032) & (K Units) Table 166. North America Cilostazol Sales Market Share Forecast by Country (2027-2032) Table 167. North America Cilostazol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America Cilostazol Market Size by Country (2021-2026) & (US$ Million) Table 169. North America Cilostazol Market Share by Country (2021-2026) Table 170. North America Cilostazol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America Cilostazol Market Share Forecast by Country (2027-2032) Table 172. Europe Cilostazol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Europe Cilostazol Sales by Country (2021-2026) & (K Units) Table 174. Europe Cilostazol Sales Market Share by Country (2021-2026) Table 175. Europe Cilostazol Sales Forecast by Country (2027-2032) & (K Units) Table 176. Europe Cilostazol Sales Market Share Forecast by Country (2027-2032) Table 177. Europe Cilostazol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe Cilostazol Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe Cilostazol Market Share by Country (2021-2026) Table 180. Europe Cilostazol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe Cilostazol Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Cilostazol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Cilostazol Sales by Country (2021-2026) & (K Units) Table 184. Asia-Pacific Cilostazol Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific Cilostazol Sales Forecast by Country (2027-2032) & (K Units) Table 186. Asia-Pacific Cilostazol Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Cilostazol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Cilostazol Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific Cilostazol Market Share by Country (2021-2026) Table 190. Asia-Pacific Cilostazol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific Cilostazol Market Share Forecast by Country (2027-2032) Table 192. Latin America Cilostazol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 193. Latin America Cilostazol Sales by Country (2021-2026) & (K Units) Table 194. Latin America Cilostazol Sales Market Share by Country (2021-2026) Table 195. Latin America Cilostazol Sales Forecast by Country (2027-2032) & (K Units) Table 196. Latin America Cilostazol Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America Cilostazol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America Cilostazol Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America Cilostazol Market Share by Country (2021-2026) Table 200. Latin America Cilostazol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America Cilostazol Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Cilostazol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Cilostazol Sales by Country (2021-2026) & (K Units) Table 204. Middle East and Africa Cilostazol Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa Cilostazol Sales Forecast by Country (2027-2032) & (K Units) Table 206. Middle East and Africa Cilostazol Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Cilostazol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Cilostazol Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa Cilostazol Market Share by Country (2021-2026) Table 210. Middle East and Africa Cilostazol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa Cilostazol Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Cilostazol Distributors List Table 215. Cilostazol Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Cilostazol Image Figure 2. Global Cilostazol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cilostazol Market Size (2021-2032) & (US$ Million) Figure 4. Global Cilostazol Sales (2021-2032) & (K Units) Figure 5. Injection Cilostazol Image Figure 6. Global Injection Cilostazol Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Cilostazol Image Figure 8. Global Oral Cilostazol Sales YoY Growth (2021-2032) & (K Units) Figure 9. Freeze-dried Powder Cilostazol Image Figure 10. Global Freeze-dried Powder Cilostazol Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Cilostazol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cilostazol Market Share by Type 2025 VS 2032 Figure 13. North America Cilostazol Sales Market Share in Volume by Type in 2025 Figure 14. North America Cilostazol Sales Market Share in Value by Type in 2025 Figure 15. Europe Cilostazol Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cilostazol Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cilostazol Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cilostazol Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cilostazol Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cilostazol Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cilostazol Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cilostazol Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cilostazol Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cilostazol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cilostazol Market Share by Application 2025 VS 2032 Figure 33. North America Cilostazol Sales Market Share in Volume by Application in 2025 Figure 34. North America Cilostazol Sales Market Share in Value by Application in 2025 Figure 35. Europe Cilostazol Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cilostazol Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cilostazol Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cilostazol Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cilostazol Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cilostazol Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cilostazol Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cilostazol Sales Market Share in Value by Application in 2025 Figure 43. North America Cilostazol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cilostazol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cilostazol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cilostazol Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cilostazol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cilostazol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cilostazol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cilostazol Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cilostazol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cilostazol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cilostazol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cilostazol Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cilostazol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cilostazol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cilostazol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cilostazol Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cilostazol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cilostazol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cilostazol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cilostazol Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cilostazol Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cilostazol Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Cilostazol
  • Oral Cilostazol
  • Freeze-dried Powder Cilostazol
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chongqing Pharscin pharmaceutical
  • Zhejiang Weikang Pharmaceutical
  • Abbott
  • Takeda
  • Teva
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Chengdu Leer Pharmaceutical
  • Yantai Yisheng Pharmaceutical
  • Squibb
  • Sandoz
  • Otsuka Pharmaceutical
  • Mayne Pharma
  • Hikma Pharmaceuticals
  • Cadila Pharmaceuticals
  • Bedford Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cilostazol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cilostazol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cilostazol Market by Type
  6. 1.3.1 Injection Cilostazol
  7. 1.3.2 Oral Cilostazol
  8. 1.3.3 Freeze-dried Powder Cilostazol
  9. 1.4 Global Cilostazol Market Size by Type
  10. 1.4.1 Global Cilostazol Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cilostazol Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cilostazol Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cilostazol Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cilostazol Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cilostazol Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cilostazol Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cilostazol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cilostazol Industry Trends
  2. 2.2 Cilostazol Industry Drivers
  3. 2.3 Cilostazol Industry Opportunities and Challenges
  4. 2.4 Cilostazol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cilostazol Revenue (2021-2026)
  2. 3.2 Global Top Players by Cilostazol Sales (2021-2026)
  3. 3.3 Global Top Players by Cilostazol Price (2021-2026)
  4. 3.4 Global Cilostazol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cilostazol Major Company Production Sites & Headquarters
  6. 3.6 Global Cilostazol Company, Product Type & Application
  7. 3.7 Global Cilostazol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cilostazol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cilostazol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cilostazol Tier 1, Tier 2, and Tier 3
4 Cilostazol Regional Status and Outlook
  1. 4.1 Global Cilostazol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cilostazol Historic Market Size by Region
  3. 4.2.1 Global Cilostazol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cilostazol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cilostazol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cilostazol Forecasted Market Size by Region
  7. 4.3.1 Global Cilostazol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cilostazol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cilostazol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cilostazol by Application
  1. 5.1 Cilostazol Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Cilostazol Market Size by Application
  6. 5.2.1 Global Cilostazol Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cilostazol Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cilostazol Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cilostazol Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cilostazol Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cilostazol Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cilostazol Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cilostazol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Pharscin pharmaceutical
  2. 6.1.1 Chongqing Pharscin pharmaceutical Company Information
  3. 6.1.2 Chongqing Pharscin pharmaceutical Business Overview
  4. 6.1.3 Chongqing Pharscin pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Pharscin pharmaceutical Cilostazol Product Portfolio
  6. 6.1.5 Chongqing Pharscin pharmaceutical Recent Developments
  7. 6.2 Zhejiang Weikang Pharmaceutical
  8. 6.2.1 Zhejiang Weikang Pharmaceutical Company Information
  9. 6.2.2 Zhejiang Weikang Pharmaceutical Business Overview
  10. 6.2.3 Zhejiang Weikang Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolio
  12. 6.2.5 Zhejiang Weikang Pharmaceutical Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Abbott Cilostazol Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Takeda
  20. 6.4.1 Takeda Company Information
  21. 6.4.2 Takeda Business Overview
  22. 6.4.3 Takeda Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takeda Cilostazol Product Portfolio
  24. 6.4.5 Takeda Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Cilostazol Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Cilostazol Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Cilostazol Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Cilostazol Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK Cilostazol Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 Chengdu Leer Pharmaceutical
  56. 6.10.1 Chengdu Leer Pharmaceutical Company Information
  57. 6.10.2 Chengdu Leer Pharmaceutical Business Overview
  58. 6.10.3 Chengdu Leer Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Leer Pharmaceutical Cilostazol Product Portfolio
  60. 6.10.5 Chengdu Leer Pharmaceutical Recent Developments
  61. 6.11 Yantai Yisheng Pharmaceutical
  62. 6.11.1 Yantai Yisheng Pharmaceutical Company Information
  63. 6.11.2 Yantai Yisheng Pharmaceutical Business Overview
  64. 6.11.3 Yantai Yisheng Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Yantai Yisheng Pharmaceutical Cilostazol Product Portfolio
  66. 6.11.5 Yantai Yisheng Pharmaceutical Recent Developments
  67. 6.12 Squibb
  68. 6.12.1 Squibb Company Information
  69. 6.12.2 Squibb Business Overview
  70. 6.12.3 Squibb Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Squibb Cilostazol Product Portfolio
  72. 6.12.5 Squibb Recent Developments
  73. 6.13 Sandoz
  74. 6.13.1 Sandoz Company Information
  75. 6.13.2 Sandoz Business Overview
  76. 6.13.3 Sandoz Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sandoz Cilostazol Product Portfolio
  78. 6.13.5 Sandoz Recent Developments
  79. 6.14 Otsuka Pharmaceutical
  80. 6.14.1 Otsuka Pharmaceutical Company Information
  81. 6.14.2 Otsuka Pharmaceutical Business Overview
  82. 6.14.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Otsuka Pharmaceutical Cilostazol Product Portfolio
  84. 6.14.5 Otsuka Pharmaceutical Recent Developments
  85. 6.15 Mayne Pharma
  86. 6.15.1 Mayne Pharma Company Information
  87. 6.15.2 Mayne Pharma Business Overview
  88. 6.15.3 Mayne Pharma Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Mayne Pharma Cilostazol Product Portfolio
  90. 6.15.5 Mayne Pharma Recent Developments
  91. 6.16 Hikma Pharmaceuticals
  92. 6.16.1 Hikma Pharmaceuticals Company Information
  93. 6.16.2 Hikma Pharmaceuticals Business Overview
  94. 6.16.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Hikma Pharmaceuticals Cilostazol Product Portfolio
  96. 6.16.5 Hikma Pharmaceuticals Recent Developments
  97. 6.17 Cadila Pharmaceuticals
  98. 6.17.1 Cadila Pharmaceuticals Company Information
  99. 6.17.2 Cadila Pharmaceuticals Business Overview
  100. 6.17.3 Cadila Pharmaceuticals Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cadila Pharmaceuticals Cilostazol Product Portfolio
  102. 6.17.5 Cadila Pharmaceuticals Recent Developments
  103. 6.18 Bedford Laboratories
  104. 6.18.1 Bedford Laboratories Company Information
  105. 6.18.2 Bedford Laboratories Business Overview
  106. 6.18.3 Bedford Laboratories Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bedford Laboratories Cilostazol Product Portfolio
  108. 6.18.5 Bedford Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Cilostazol Sales by Country
  2. 7.1.1 North America Cilostazol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cilostazol Sales by Country (2021-2026)
  4. 7.1.3 North America Cilostazol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cilostazol Market Size by Country
  6. 7.2.1 North America Cilostazol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cilostazol Market Size by Country (2021-2026)
  8. 7.2.3 North America Cilostazol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cilostazol Sales by Country
  2. 8.1.1 Europe Cilostazol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cilostazol Sales by Country (2021-2026)
  4. 8.1.3 Europe Cilostazol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cilostazol Market Size by Country
  6. 8.2.1 Europe Cilostazol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cilostazol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cilostazol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cilostazol Sales by Country
  2. 9.1.1 Asia-Pacific Cilostazol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cilostazol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cilostazol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cilostazol Market Size by Country
  6. 9.2.1 Asia-Pacific Cilostazol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cilostazol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cilostazol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cilostazol Sales by Country
  2. 10.1.1 South America Cilostazol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cilostazol Sales by Country (2021-2026)
  4. 10.1.3 South America Cilostazol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cilostazol Market Size by Country
  6. 10.2.1 South America Cilostazol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cilostazol Market Size by Country (2021-2026)
  8. 10.2.3 South America Cilostazol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cilostazol Sales by Country
  2. 11.1.1 Middle East and Africa Cilostazol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cilostazol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cilostazol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cilostazol Market Size by Country
  6. 11.2.1 Middle East and Africa Cilostazol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cilostazol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cilostazol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cilostazol Value Chain Analysis
  2. 12.1.1 Cilostazol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cilostazol Production Mode & Process
  7. 12.2 Cilostazol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cilostazol Distributors
  10. 12.2.3 Cilostazol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst